RE:Where are we headingAt the moment it looks like we're headed to 20 cents.
The immediate trend aside, I think we are headed to FDA approval and an sp of $10 to $20. But the timeframe escapes me...Worst case is we have to completely finish the trial before approval. We've treated about half of the patients, To treat 56 more at a rate of 3 a month would bring us to Dec 2024. Another 450 days and all patients would have had their final evaluations and we will be at March 2026. Then we apply and wait for FDA approval.
But the rate of 3 patients per month could speed up if demand for our treatment increased. I wonder how that could be made to happen? Publicity? And then we could get accelerated approval from the FDA. But first Theralase will have to apply for it.
It's also possible the sp will be higher than $20, especially if more clinical trials get started and have promising results.